Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-25T17:40:59.965Z Has data issue: false hasContentIssue false

Chapter 18 - Fetal Dysrhythmias: Diagnosis and Clinical Management

from Fetal Dysrhythmias

Published online by Cambridge University Press:  21 October 2019

By
Julene S. Carvalho
Edited by
Mark D. Kilby ,
Anthony Johnson  and
Dick Oepkes
Mark D. Kilby
Affiliation:
University of Birmingham
Anthony Johnson
Affiliation:
University of Texas Medical School at Houston
Dick Oepkes
Affiliation:
Leids Universitair Medisch Centrum
Get access

Summary

Assessment of fetal heart rate (FHR) and its regularity is part of clinical management of all pregnancies during routine antenatal visits. By simple auscultation of the fetal heart, doctors and midwives can promptly detect abnormal patterns (‘fetal dysrhythmia’), and bradycardias, tachycardias, and irregular rhythms are therefore easily recognized.

Type
Chapter
Information
Fetal Therapy
Scientific Basis and Critical Appraisal of Clinical Benefits
 , pp. 176 - 190
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Glickstein, JS, Buyon, J, Friedman, D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol. 2000; 86: 236–9.CrossRefGoogle ScholarPubMed
Fouron, JC, Fournier, A, Proulx, F, et al. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings. Heart. 2003; 89: 1211–16.CrossRefGoogle ScholarPubMed
Carvalho, JS, Prefumo, F, Ciardelli, V, et al. Evaluation of fetal arrhythmias from simultaneous pulsed wave Doppler in pulmonary artery and vein. Heart. 2007; 93: 1448–53.CrossRefGoogle ScholarPubMed
Wacker-Gussmann, A, Plankl, C, Sewald, M, et al. Fetal cardiac time intervals in healthy pregnancies – an observational study by fetal ECG (Monica Healthcare System). J Perin Medicine. 2017; 46: 587–92.Google Scholar
Wacker-Gussmann, A, Strasburger, JF, Srinivasan, S, et al. Fetal atrial flutter: electrophysiology and associations with rhythms involving an accessory pathway. J Am Heart Assoc. 2016; 5: e003673.Google Scholar
Eswaran, H, Escalona-Vargas, D, Bolin, EH, et al. Fetal magnetocardiography using optically pumped magnetometers: a more adaptable and less expensive alternative? Prenat Diagn. 2017; 37: 193–6.Google Scholar
Rasiah, SV, Ewer, AK, Miller, P, et al. Prenatal diagnosis, management and outcome of fetal dysrhythmia: a tertiary fetal medicine centre experience over an eight-year period. Fetal DiagnTher. 2011; 30: 122–7.Google ScholarPubMed
Fouron, JC. Fetal arrhythmias: the Saint-Justine hospital experience. Prenat Diagn. 2004; 24: 1068–80.Google Scholar
Cuneo, BF, Strasburger, JF, Wakai, RT, et al. Conduction system disease in fetuses evaluated for irregular cardiac rhythm. Fetal Diagn Ther. 2006; 21: 307–13.CrossRefGoogle ScholarPubMed
Srinivasan, S, Strasburger, J. Overview of fetal arrhythmias. Curr Opin Pediatr. 2008; 20: 522–31.Google Scholar
Eliasson, H, Wahren-Herlenius, M, Sonesson, SE. Mechanisms in fetal bradyarrhythmia: 65 cases in a single center analyzed by Doppler flow echocardiographic techniques. Ultrasound Obstet Gynecol. 2011; 37:172–8.CrossRefGoogle Scholar
Wiggins, DL, Strasburger, JF, Gotteiner, NL, et al. Magnetophysiologic and echocardiographic comparison of blocked atrial bigeminy and 2:1 atrioventricular block in the fetus. Heart Rhythm. 2013; 10: 1192–8.Google Scholar
Carvalho, JS. Primary bradycardia: keys and pitfalls in diagnosis. Ultrasound Obstet Gynecol. 2014; 44: 125–30.Google Scholar
Strasburger, JF, Wakai, RT. Fetal cardiac arrhythmia detection and in utero therapy. Nat Rev Cardiol. 2010; 7: 277–90.Google Scholar
Jaeggi, ET, Carvalho, JS, De Groot, E, et al. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Circulation. 2011; 124: 1747–54.CrossRefGoogle ScholarPubMed
Uzun, O, Babaoglu, K, Sinha, A, et al. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Cardiol Young. 2012; 22: 372–80.Google Scholar
Gembruch, U. Fetal Tachyarrhythmia. In Yagel, S, Silverman, NH, Gembruch, U, eds., Fetal Cardiology: Maternal-Fetal Medicine. New York: Informa Healthcare, 2009, pp. 461–81.Google Scholar
Oudijk, MA, Stoutenbeek, P, Sreeram, N, et al. Persistent junctional reciprocating tachycardia in the fetus. J Matern Fetal Neonatal Med. 2003; 13: 191–6.CrossRefGoogle ScholarPubMed
Zaidi, SJ, Siddiqui, S, Cuneo, BF, et al. Prenatal diagnosis and management of junctional ectopic tachycardia. Heart Rhythm Case Rep. 2017; 3: 503–8.Google Scholar
Dubin, AM, Cuneo, BF, Strasburger, JF, et al. Congenital junctional ectopic tachycardia and congenital complete atrioventricular block: a shared etiology? Heart Rhythm. 2005; 2: 313–15.Google Scholar
Kang, SL, Howe, D, Coleman, M, et al. Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone. Cardiol Young. 2015; 25: 447–53.Google Scholar
Shah, A, Moon-Grady, A, Bhogal, N, et al. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Am J Cardiol. 2012; 109: 1614–18.CrossRefGoogle ScholarPubMed
Sridharan, S, Sullivan, I, Tomek, V, et al. Flecainide versus digoxin for fetal supraventricular tachycardia: comparison of two drug treatment protocols. Heart Rhythm. 2016; 13: 1913–19.Google Scholar
Ekman-Joelsson, BM, Mellander, M, Lagnefeldt, L, et al. Foetal tachyarrhythmia treatment remains challenging even if the vast majority of cases have a favourable outcome. Acta Paediatr. 2015; 104: 1090–7.CrossRefGoogle ScholarPubMed
Strizek, B, Berg, C, Gottschalk, I, et al. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Heart Rhythm. 2016; 13: 1283–8.CrossRefGoogle ScholarPubMed
Ekiz, A, Kaya, B, Bornaun, H, et al. Flecainide as first-line treatment for fetal supraventricular tachycardia. J Matern Fetal Neonatal Med. 2018; 31: 407–12.Google Scholar
Hill, GD, Kovach, JR, Saudek, DE, et al. Transplacental treatment of fetal tachycardia: a systematic review and meta-analysis. Prenat Diagn. 2017; 37: 1076–83.Google Scholar
Strasburger, JF, Cuneo, BF, Michon, MM, et al. Amiodarone therapy for drug-refractory fetal tachycardia. Circulation. 2004; 109: 375–9.Google Scholar
Jouannic, JM, Delahaye, S, Fermont, L, et al. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Prenat Diagn. 2003; 23: 152–6.Google Scholar
Parilla, BV, Strasburger, JF, Socol, ML. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Am J Perinatol. 1996; 13: 483–6.CrossRefGoogle ScholarPubMed
Vigneswaran, TV, Callaghan, N, Andrews, RE, et al. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia. Heart Rhythm. 2014; 11: 2047–53.CrossRefGoogle ScholarPubMed
Cuneo, BF, Strasburger, JF. We only find what we look for: fetal heart rate and the diagnosis of long-QT syndrome. Circ Arrhythm Electrophysiol. 2015; 8: 760–2.Google Scholar
Lopes, LM, Tavares, GM, Damiano, AP, et al. Perinatal outcome of fetal atrioventricular block: one-hundred-sixteen cases from a single institution. Circulation. 2008; 118: 1268–75.Google Scholar
Glatz, AC, Gaynor, JW, Rhodes, LA, et al. Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth. J Thorac Cardiovasc Surg. 2008; 136: 767–73.Google Scholar
Baruteau, AE, Fouchard, S, Behaghel, A, et al. Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: a multicentre study. Eur Heart J. 2012; 33: 622–9.Google Scholar
Eliasson, H, Sonesson, SE, Sharland, G, et al. Isolated atrioventricular block in the fetus: a retrospective multinational, multicentre study of 175 patients. Circulation. 2011; 124: 1919–26.Google Scholar
Van Hare, GF. Magnetocardiography in the diagnosis of fetal arrhythmias. Heart Rhythm. 2013; 10: 1199–200.Google Scholar
Buyon, JP, Hiebert, R, Copel, J, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol. 1998; 31: 1658–66.Google Scholar
Levesque, K, Morel, N, Maltret, A, et al. Description of 214 cases of autoimmune congenital heart block: results of the French neonatal lupus syndrome. Autoimmun Rev. 2015; 14: 1154–60.Google Scholar
Friedman, DM, Kim, MY, Copel, JA, et al. Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block: The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study. Circulation. 2008; 117: 485–93.Google Scholar
Jaeggi, E, Laskin, C, Hamilton, R, et al. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol. 2010; 55: 2778–84.Google Scholar
Hutter, D, Silverman, ED, Jaeggi, ET. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol. 2010; 72: 235–41.Google Scholar
Saxena, A, Izmirly, PM, Mendez, B, et al. Prevention and treatment in utero of autoimmune-associated congenital heart block. Cardiol Rev. 2014; 22: 263–7.Google Scholar
Vest, AN, Zhou, L, Huang, X, et al. Design and testing of a transcutaneous RF recharging system for a fetal micropacemaker. IEEE Trans Biomed Circuits Syst. 2017; 11: 336–46.Google Scholar
Cuneo, BF, Mitchell, MB, Marwan, AI, et al. Ex utero intrapartum treatment to ventricular pacing: a novel delivery strategy for complete atrioventricular block with severe bradycardia. Fetal Diagn Ther. 2017; 42: 311–14.Google Scholar
Izmirly, PM, Costedoat-Chalumeau, N, Pisoni, C, et al. Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/RO associated cardiac manifestations of neonatal lupus. Circulation. 2012; 126: 76–82.Google Scholar
Ciardulli, A, D’Antonio, F, Magro-Malosso, ER, et al. Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018; 97: 787–94.Google Scholar
Van den Berg, NW, Slieker, MG, van Beynum, IM, et al. Fluorinated steroids do not improve outcome of isolated atrioventricular block. Int J Cardiol. 2016; 225: 167–71.Google Scholar
Izmirly, PM, Saxena, A, Sahl, SK, et al. Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system. Ann Rheum Dis. 2016; 75: 1161–5.Google Scholar
Cuneo, BF, Ambrose, SE, Tworetzky, W. Detection and successful treatment of emergent anti-SSA-mediated fetal atrioventricular block. Am J Obstet Gynecol. 2016; 215: 27–8.Google Scholar
Cuneo, BF, Zhao, H, Strasburger, JF, et al. Atrial and ventricular rate response and patterns of heart rate acceleration during maternal-fetal terbutaline treatment of fetal complete heart block. Am J Cardiol. 2007; 100: 661–5.Google Scholar
Friedman, DM, Llanos, C, Izmirly, PM, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum. 2010; 62: 1138–46.CrossRefGoogle Scholar
Pisoni, CN, Brucato, A, Ruffatti, A, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum. 2010; 62: 1147–52.Google Scholar
Trucco, SM, Jaeggi, E, Cuneo, B, et al. Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol. 2011; 57: 715–23.Google Scholar
Ruffatti, A, Cerutti, A, Favaro, M, et al. Plasmapheresis, intravenous immunoglobulins and bethametasone – a combined protocol to treat autoimmune congenital heart block: a prospective cohort study. Clin Exp Rheumatol. 2016; 34: 706–13.Google Scholar
Rein, AJ, Mevorach, D, Perles, Z, et al. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/ RO-SSB/LA antibodies. a prospective, observational, fetal kinetocardiogram-based study. Circulation. 2009; 119: 1867–72.Google Scholar
Jaeggi, ET, Silverman, ED, Laskin, C, et al. Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol. 2011; 57: 1487–92.Google Scholar
Bergman, G, Eliasson, H, Bremme, K, et al. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance. Ultrasound Obstet Gynecol. 2009; 34: 543–9.Google Scholar
Kan, N, Silverman, ED, Kingdom, J, et al. Serial echocardiography for immune-mediated heart disease in the fetus: results of a risk-based prospective surveillance strategy. Prenat Diagn. 2017; 37: 375–82.Google Scholar
Cuneo, BF, Moon-Grady, AJ, Sonesson, SE, et al. Heart sounds at home: feasibility of an ambulatory fetal heart rhythm surveillance program for anti-SSA-positive pregnancies. J Perinatol. 2017; 37: 226–30.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×